iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Commitments and Contingencies (Details)

v3.20.1

Commitments and Contingencies (Details)				1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
Commitments and Contingencies (Details)	Apr. 16, 2020 USD ($)	Jan. 14, 2014 USD ($)	Apr. 30, 2013 USD ($) item	Dec. 31, 2015 USD ($)	Mar. 31, 2020 USD ($)	Mar. 31, 2019 USD ($)	Mar. 31, 2020 USD ($)	Mar. 31, 2019 USD ($)	Jun. 30, 2015 USD ($)
Commitments and Contingencies [Line Items]
Research and Development Expense, Total					$ 999,000	$ 1,453,000	$ 2,864,000	$ 3,850,000
Royalty Guarantees, Commitments, Amount					200,000		200,000
Licensing Fees					2,000	$ 3,800	$ 154,000	$ 156,000
Long Term Purchase Commitment Expire Date							Dec. 31, 2015
Agreement Term		5 years
Commitments [Member]
Commitments and Contingencies [Line Items]
Long-term Purchase Commitment, Amount				$ 3,000,000
Royalty Guarantees, Commitments, Amount				$ 3,000,000
License Cost		$ 30,627
Initial license fee		20,000
Settlement Agreement [Member]
Commitments and Contingencies [Line Items]
Number of Installments \| item			3
Prepaid Expense			$ 1,000,000
Amended Agreement [Member]
Commitments and Contingencies [Line Items]
Research and Development Expense, Total									$ 2,100,000
Minimum [Member] \| Commitments [Member]
Commitments and Contingencies [Line Items]
License Cost		25,000
Maximum [Member] \| Commitments [Member]
Commitments and Contingencies [Line Items]
License Cost		$ 150,000
Fraunhofer [Member]
Commitments and Contingencies [Line Items]
Royalty Guarantees, Commitments, Amount					$ 4,000,000		$ 4,000,000
Fraunhofer [Member] \| Settlement Agreement [Member]
Commitments and Contingencies [Line Items]
Agreement Term							15 years
Subsequent event \| PPP Loan
Commitments and Contingencies [Line Items]
Proceeds from debt received	$ 600,000
iBio Launch [Member] \| Fraunhofer [Member] \| Settlement Agreement [Member]
Commitments and Contingencies [Line Items]
Percentage royalty on product sales							1.00%
Royalty Commitment Percentage Payable on Licensing							10.00%

- Definition

The period of time over which the agreement applies.

+ References

No definition available.

+ Details

Name:	ibio_AgreementTerm
Namespace Prefix:	ibio_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- References

No definition available.

+ Details

Name:	ibio_CommitmentsAndContingenciesLineItems
Namespace Prefix:	ibio_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of initial license fee paid by the company during the reporting period.

+ References

No definition available.

+ Details

Name:	ibio_InitialLicenseFee
Namespace Prefix:	ibio_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Costs incurred and are directly related to generating Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark.

+ References

No definition available.

+ Details

Name:	ibio_LicenseCost
Namespace Prefix:	ibio_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of licensing fees.

+ References

No definition available.

+ Details

Name:	ibio_LicensingFees
Namespace Prefix:	ibio_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Long term purchase commitment expired date.

+ References

No definition available.

+ Details

Name:	ibio_LongTermPurchaseCommitmentExpireDate
Namespace Prefix:	ibio_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of installments.

+ References

No definition available.

+ Details

Name:	ibio_NumberOfInstallments
Namespace Prefix:	ibio_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Under the royalty commitment, the percentage payable on licensing.

+ References

No definition available.

+ Details

Name:	ibio_RoyaltyCommitmentPercentagePayableOnLicensing
Namespace Prefix:	ibio_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Under the royalty commitment, the percentage payable on product sales.

+ References

No definition available.

+ Details

Name:	ibio_RoyaltyCommitmentPercentagePayableOnProductSales
Namespace Prefix:	ibio_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The minimum amount the entity agreed to spend under the long-term purchase commitment.

+ References

No definition available.

+ Details

Name:	us-gaap_LongTermPurchaseCommitmentAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.10)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.10)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

+ Details

Name:	us-gaap_PrepaidExpenseCurrentAndNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfDebt
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount the entity has committed to make for future royalty guarantees.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 928
-SubTopic 440
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6473578&loc=d3e63223-108013

+ Details

Name:	us-gaap_RoyaltyGuaranteesCommitmentsAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_FinancialInstrumentAxis=us-gaap_CommitmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=ibio_SettlementAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=ibio_AmendedAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=ibio_FraunhoferMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=ibio_PaycheckProtectionProgramLoanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ibio_IbioLaunchMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: